These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13898276)

  • 1. [Study of the serum copper-oxidase activity in 8 families affected by Struempell-Wilson disease (hepatolentricular degeneration)].
    GIAGHEDDU M; CHESS-PERLE E
    Sist Nerv; 1961; 13():237-52. PubMed ID: 13898276
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in serum copper and PPD-oxidase in different diseases. II. Comparative studies in Wilson's disease schizophrenia and Parkinsonism.
    Chitre VS; Punekar BD
    Indian J Med Res; 1970 May; 58(5):563-73. PubMed ID: 5473254
    [No Abstract]   [Full Text] [Related]  

  • 4. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 5. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 7. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Iorio R; Ranucci G
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26863385
    [No Abstract]   [Full Text] [Related]  

  • 8. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Sintusek P; Dhawan A
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26690865
    [No Abstract]   [Full Text] [Related]  

  • 9. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning].
    Deng SL; Li XF; Guo XL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma copper and iron levels and plasma para-phenylene diamine oxidase activity (plasma copper oxidase activity) in kwashiorkor.
    REIFF B; SCHNIEDEN H
    Blood; 1959 Aug; 14(8):967-71. PubMed ID: 13671089
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity.
    Sunderman FW; Nomoto S
    Clin Chem; 1970 Nov; 16(11):903-10. PubMed ID: 5473551
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical diagnosis of hepatolenticular degeneration].
    Wu WY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):216-9. PubMed ID: 7183432
    [No Abstract]   [Full Text] [Related]  

  • 15. [The content of copper in the blood serum in normal subjects and in patients with various diseases of the brain].
    GEKHT BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1961; 61():707-12. PubMed ID: 13704239
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum 'free' copper in Wilson disease.
    Walshe JM
    QJM; 2012 May; 105(5):419-23. PubMed ID: 22139498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
    WALSHE JM
    J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
    [No Abstract]   [Full Text] [Related]  

  • 19. Some observations on the serum copper and paraphenylene diamine oxidase (PPD oxidase, copper oxidase) activity in nutritional oedema syndrome (kwashiorkor).
    CHITRE VS; SANTHANAGOPALAN T; RAMANATHAN MK; BALASUBRAHMANYAN M
    Indian J Pathol Bacteriol; 1962 Apr; 5():93-6. PubMed ID: 13879050
    [No Abstract]   [Full Text] [Related]  

  • 20. HBV and HCV infections in Wilson's disease patients: copper overload could be protective?
    Liggi M; Sini M; Sorbello O; Civolani A; Demelia L
    Clin Biochem; 2012 Sep; 45(13-14):1095-6. PubMed ID: 22569595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.